Immune Complex Corporation (AKA: Bios Development~Synthetic Genetics Inc) Profile last edited on: 2/9/2023
CAGE: -----
UEI: ----------
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
3347 Industrial Court Suite A
San Diego, CA 92121
San Diego, CA 92121
| (619) 459-7083 |
| N/A |
| N/A |
Location: Single
Congr. District: 52
County: San Diego
Congr. District: 52
County: San Diego
Public Profile
Immune Complex Corporation manufactures and markets custom synthetic oligonucleotides used in detecting the presence of specific DNA sequences. The firm developed a vaccine delivery system based upon the Hepatitis- B core protein.In September1997 BioQuest, Inc. (NASDAQ: HIVX) acquired Immune Complex Corporation in a stock and cash deal.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2001 | 2 | NIH | $956,254 | |
| Project Title: Malaria Vaccine | ||||
| 2000 | 2 | NIH | $3,219,436 | |
| Project Title: Development of Antibodies to Human Cytochromes P450 | ||||
| 2000 | 1 | NIH | $100,000 | |
| Project Title: Bioreactor Synthesis Of Cytochrome P450 Metabolites | ||||
| 1999 | 1 | NIH | $98,219 | |
| Project Title: High Throughout Colormetric Genotyping | ||||
| 1998 | 1 | NIH | $100,000 | |
| Project Title: Therapeutic Treatment For Chronic Human Renal Rejection | ||||
Key People / Management
Henry J Barnes
Ashley J Birkett
David Johnson
Ed Lusby
Ashley J Birkett
David Johnson
Ed Lusby
Company News
There are no news available.
